Citation: Im. Gralnek, Diagnosis and management of gastroesophageal reflux disease in the primarycare setting: Can health-related quality of life play a role?, AM J GASTRO, 96(8), 2001, pp. S54-S56
Authors:
Gralnek, IM
Hays, RD
Kilbourne, A
Rosen, HR
Keeffe, EB
Artinian, L
Kim, S
Lazarovici, D
Jensen, DM
Busuttil, RW
Martin, P
Citation: Im. Gralnek et al., Development and evaluation of the liver disease quality of life instrumentin persons with advanced, chronic liver disease - The LDQOL 1.0, AM J GASTRO, 95(12), 2000, pp. 3552-3565
Authors:
Gralnek, IM
Jensen, DM
Kovacs, TOG
Jutabha, R
Machicado, GA
Gornbein, J
King, J
Cheng, S
Jensen, ME
Citation: Im. Gralnek et al., The economic impact of esophageal variceal hemorrhage: Cost-effectiveness implications of endoscopic therapy, HEPATOLOGY, 29(1), 1999, pp. 44-50
Authors:
Gralnek, IM
Liu, HG
Shapiro, MF
Martin, P
Citation: Im. Gralnek et al., The United States liver donor population in the 1990s - A descriptive, population-based comparative study, TRANSPLANT, 67(7), 1999, pp. 1019-1023
Authors:
Fass, R
Ofman, JJ
Gralnek, IM
Johnson, C
Camargo, E
Sampliner, RE
Fennerty, MB
Citation: R. Fass et al., Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease, ARCH IN MED, 159(18), 1999, pp. 2161-2168